Dear Neogen Customer
We are writing to inform you that, effective 1 July 2026, as part of the Neogen Genomics divestiture process, a new subsidiary company, GeneSeek UK, will be established. Neogen will transfer its genomics business and related assets into this new entity in preparation for the business conveying to Zoetis.
What this means:
Contracts:
From July 1st, any existing contracts you have with Neogen will be legally assigned to GeneSeek UK. However, there are no changes to the terms and conditions, and there will be no impact on the services you receive. While the legal entity name and banking details will change, all other aspects of our relationship remain the same. You will continue to work with the same team, receive the same high level of service, and have access to the same products and support you rely on today.
Invoicing:
Any invoices that you receive on or after July 1st will be issued by GeneSeek UK. Payments for invoices issued by GeneSeek UK should be remitted to the updated bank details below:
Updated Banking information effective July 1, 2026:
Bank: Royal Bank of Scotland
Name: GeneSeek UK LTD (SC862923)
Account Number: 19416225
Sort code: 83-15-26
BIC: RBOSGB2L
IBAN: GB59RBOS83152619416225
Until 1 July 2026, all business operations will continue to be conducted under Neogen Europe. Please continue to use current processes and banking details until 30th June.
We also ask that you make note of the ordering email address you use for placing orders, to ensure your requests are processed correctly.
Emails:
Orders - formsgenomics@neogen.com
Receivables - ARGeneseekUK@neogen.com
Payables - APGeneseekUK@neogen.com
Accounts - Genomicscustomerservice@neogen.com
Phone: +44 (0) 1292 526 099
Please do not hesitate to contact us if you have any questions or concerns.



